The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrooks Macdonald Regulatory News (BRK)

Share Price Information for Brooks Macdonald (BRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,050.00
Bid: 2,010.00
Ask: 2,050.00
Change: 10.00 (0.49%)
Spread: 40.00 (1.99%)
Open: 1,990.00
High: 2,050.00
Low: 1,990.00
Prev. Close: 2,040.00
BRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director appointment

16 Feb 2023 07:00

RNS Number : 0700Q
Brooks Macdonald Group PLC
16 February 2023
 

16 February 2023

 

BROOKS MACDONALD GROUP PLC

 

Director appointment

 

Brooks Macdonald Group plc ("The Group", "Brooks Macdonald") is pleased to announce the appointment of James Rawlingson as Non-Executive Director effective 2 March 2023. James will in due course assume the role of Chairman of the Audit Committee, subject to regulatory approval.

 

James currently serves as Chairman of the Audit and Risk Committee at Citibank UK, Chairman of the Audit and Risk Assurance Committee at the Foreign Office's executive agency Wilton Park, and Chairman of the Board at Novai Ltd. In his executive career James has held senior positions at Coutts, UBS Wealth, Charles Stanley plc and Arix Bioscience plc.

 

Commenting on the appointment, Acting Chairman Richard Price said: "I am delighted that James is joining the Board. James has had an extensive career and his sector experience will provide valuable insight as the Company continues towards its strategic goals."

 

AIM disclosures

 

During the five years immediately preceding the date of this announcement, James Hedley Rawlingson, who is 55 years old, held the following directorships:

 

Current

 

Citibank UK Limited

Wilton Park (an Arm's Length Body of the British Foreign, Commonwealth & Development Office)

Novai Limited

 

Previous

 

Next Gen PPE limited

Arix Bioscience Holdings Limited

Arix Bioscience plc

Arthurian Life Sciences GP Limited

Als SPV Limited

Arix Capital Management Limited

Arthurian Life Sciences SPV GP Limited

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

Enquiries to:

Brooks Macdonald Group plc

Andrew Shepherd, CEO

www.brooksmacdonald.com

020 7927 4816

 

Peel Hunt LLP (Nominated Adviser and Broker)

Paul Shackleton / Andrew Buchanan / John Welch

020 7418 8900

 

FTI Consulting

Laura Ewart / Katherine Bell

brooksmacdonald@fticonsulting.com

07711 387 085 / 07976 870 961

 

Notes to editors

 

Brooks Macdonald Group plc, through its various subsidiaries, provides leading investment management services in the UK and internationally. The Group, which was founded in 1991 and began trading on AIM in 2005, had discretionary Funds under Management of £16.2 billion as at 31 December 2022.

 

Brooks Macdonald offers a range of investment management services to private high net worth individuals, pension funds, institutions, charities and trusts. The Group also provides financial planning as well as international investment management, and acts as fund manager to a range of onshore and international funds.

 

The Group has fifteen offices across the UK and Crown Dependencies including London, Birmingham, Cheltenham, East Anglia, Exeter, Leeds, Manchester, Nuneaton, Southampton, Tunbridge Wells, Scotland, Wales, Jersey, Guernsey and Isle of Man.

 

LEI: 213800WRDF8LB8MIEX37

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVSWROAUUAAR
Date   Source Headline
28th Mar 20199:36 amRNSDirectorate Change
15th Mar 20193:41 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSHalf-year Report
28th Feb 201911:04 amRNSTotal Voting Rights
26th Feb 20191:29 pmRNSHolding(s) in Company
8th Feb 201912:08 pmRNSAppointment of Chairman
6th Feb 20193:05 pmRNSHolding(s) in Company
6th Feb 20197:00 amRNSEBT Dealings
31st Jan 20197:00 amRNSTotal Voting Rights
28th Jan 20199:36 amRNSEBT Dealings
24th Jan 20197:00 amRNSTrading Update
17th Jan 201912:15 pmRNSHolding(s) in Company
14th Jan 201911:35 amRNSHolding(s) in Company
10th Jan 20199:10 amRNSProposed efficiency improvements
7th Jan 201911:59 amRNSEBT Dealings
24th Dec 201811:53 amRNSDirector/PDMR Shareholding
18th Dec 201811:16 amRNSBlock listing Interim Review
17th Dec 20183:37 pmRNSEBT Dealings
12th Dec 201812:23 pmRNSEBT Dealings
4th Dec 20184:57 pmRNSEBT Dealings
30th Nov 201812:46 pmRNSDirector/PDMR Shareholding
26th Nov 201810:12 amRNSEBT Dealings
26th Nov 201810:12 amRNSEBT Dealings
13th Nov 20187:00 amRNSDirectorate Changes
12th Nov 201810:09 amRNSEmployee Benefit Trust Dealings
9th Nov 20183:28 pmRNSHolding(s) in Company
8th Nov 20185:11 pmRNSDirector/PDMR Shareholding
6th Nov 20183:49 pmRNSDirector/PDMR Shareholding
2nd Nov 20184:35 pmRNSPrice Monitoring Extension
1st Nov 20184:56 pmRNSEBT Dealings
31st Oct 20184:11 pmRNSResult of AGM
26th Oct 20187:00 amRNSQuarterly Announcement of Funds under Management
17th Oct 20184:47 pmRNSHolding(s) in Company
8th Oct 20187:00 amRNSPosting of Annual Report and Notice of AGM
20th Sep 201812:56 pmRNSAppointment of non-executive director - Correction
20th Sep 201812:43 pmRNSFinal Results - Replacement
20th Sep 20187:00 amRNSAppointment of non-executive director
20th Sep 20187:00 amRNSFinal Results
19th Sep 20184:40 pmRNSSecond Price Monitoring Extn
19th Sep 20184:35 pmRNSPrice Monitoring Extension
22nd Aug 20184:06 pmRNSHolding(s) in Company
21st Aug 20185:13 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSDirectorate Change
26th Jul 20187:00 amRNSTrading Update
3rd Jul 20183:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20189:41 amRNSEmployee Benefit Trust Dealings
13th Jun 20184:07 pmRNSBlock Listing Application
6th Jun 20185:11 pmRNSExercise of Options and EBT dealings
30th May 20184:48 pmRNSExercise of Options
30th May 201810:08 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.